PDS Biotechnology Corporation
PDS Biotechnology Corporation (PDSB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pdsb · stock forecast · 7 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$9.00
Consensus
$9.00
+800.0% upside
Low
$9.00
Median: $9 · Last Close: $1.00
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.97 | ↓ 2.84% |
1-day model range: $0.93–$1.01. Peak: $1.01 (-2.84%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PDSB · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-25 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on PDS Biotechnology Corporation (PDSB) stock. Of the recent 52 rating actions, 0 were upgrades and 2 were downgrades. 7 analysts currently cover PDSB.
Analyst Recommendation Trends
PDSB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$11M
↑ 196.1% YoY
Revenue Next Year
$23M
↑ 105.8% YoY
EPS This Year
$-0.50
EPS Next Year
$-0.47
↓ 6.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast PDSB EPS of $-0.50 for the current fiscal year, based on estimates from 2 analysts. The PDSB revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PDSB stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PDSB price target is $9.00 (+800.0% upside), with an analyst consensus of Buy.
The PDSB short-term stock prediction for tomorrow is $0.97 (-2.84%). The PDSB stock prediction for 2030 projects a range of $0–$0.
PDS Biotechnology Corporation trades on NASDAQ under the ticker PDSB. The PDSB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.
Frequently asked questions
PDSB forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month PDSB price target is $9.00, with a high forecast of $9.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +800.0% potential upside from the current price of $1.00.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.